News from carisma therapeutics inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 09, 2021, 08:01 ET CARISMA Therapeutics to Present Data at The American Association for Cancer Research Annual Meeting

CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced...

Mar 18, 2021, 08:00 ET CARISMA Therapeutics Announces First Patient Dosed in Landmark Clinical Study Evaluating Engineered Macrophages in Humans

CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of Pennsylvania (Penn) and focused on discovering...

Mar 01, 2021, 08:01 ET CARISMA Therapeutics Completes Series B Financing Totaling $59 Million

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today the second...

Jan 07, 2021, 08:01 ET CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of Novel CAR-Macrophage Immunotherapies

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has...

Nov 09, 2020, 08:00 ET CARISMA to Present New Data at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced new...

Oct 08, 2020, 09:00 ET CARISMA Therapeutics to Present at Upcoming Healthcare Industry Conferences

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the...

Oct 05, 2020, 09:00 ET CARISMA Therapeutics to Participate in Upcoming Investor Conferences

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the...

Jul 30, 2020, 09:00 ET CARISMA Therapeutics to Participate in Upcoming Investor Conferences

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the...

Jul 27, 2020, 03:00 ET CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the U.S....

May 21, 2020, 10:49 ET Carisma Therapeutics to Present and Meet with Potential Investors at Upcoming Healthcare Investor Conferences

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the...

May 15, 2020, 09:36 ET New Data Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, shares details from new data ...

Mar 23, 2020, 12:42 ET First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Nature...

Mar 23, 2020, 12:00 ET First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Nature...

Feb 28, 2020, 16:01 ET Carisma Therapeutics to Present at March Scientific and Investor Conferences

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the...

Jan 06, 2020, 08:00 ET Carisma Therapeutics Expands Leadership with Appointments of Debora Barton as Chief Medical Officer and Tom Wilton as Chief Business Officer

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the...

Nov 16, 2019, 00:01 ET Carisma Therapeutics Announces Investor Conference Participation

Carisma Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies based on...

Jun 03, 2019, 00:01 ET Carisma Therapeutics Names Dr. Robert Petit as Chief Scientific Officer

Carisma Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies based on...

Mar 05, 2019, 09:20 ET Carisma Therapeutics Announces Upcoming Conference Participation

Carisma Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies based on...

Jun 27, 2018, 12:01 ET Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy

Carisma Therapeutics Inc., formerly CARMA Therapeutics, a privately-held biotechnology company focused on the development of macrophage-based...